Published in Am J Med on September 01, 1990
Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med (2009) 2.40
Lifestyle drugs: issues for debate. CMAJ (2001) 1.70
Defining basic services and de-insuring the rest: the wrong diagnosis and the wrong prescription. CMAJ (1995) 1.39
The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ (2000) 1.13
Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits. Cancer Nurs (2014) 0.81
Attitudes towards treatment among patients suffering from sleep disorders. A Latin American survey. BMC Fam Pract (2003) 0.77
The Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of Zaleplon. Prim Care Companion J Clin Psychiatry (2001) 0.76
Ontario palliative care statement: a template for the rest of Canada. CMAJ (1993) 0.75
Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA (1990) 10.01
Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med (1983) 8.56
Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med (1982) 7.14
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol (2001) 7.04
Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med (1991) 5.94
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med (1987) 4.57
Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q (1989) 4.49
Incidence and preventability of adverse drug events in nursing homes. Am J Med (2000) 4.33
The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA (1992) 4.28
Physician motivations for nonscientific drug prescribing. Soc Sci Med (1989) 3.84
Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis (2006) 3.48
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ (2012) 3.44
Evaluating drugs after their approval for clinical use. N Engl J Med (1993) 3.19
Risk factors for adverse drug events among nursing home residents. Arch Intern Med (2001) 3.12
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA (2000) 3.03
Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med (2000) 2.62
Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med (1994) 2.62
Paradoxical relations of drug treatment with mortality in older persons. Epidemiology (2001) 2.52
Feedback analysis and design of RF power links for low-power bionic systems. IEEE Trans Biomed Circuits Syst (2007) 2.48
Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health (1996) 2.33
Refilling and switching of antiepileptic drugs and seizure-related events. Clin Pharmacol Ther (2010) 2.31
A controlled trial of educational outreach to improve blood transfusion practice. JAMA (1993) 2.28
Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med (1993) 2.27
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens (1997) 2.21
Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med (2001) 2.13
Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. N Engl J Med (1984) 2.12
Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc (1997) 2.09
Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med (1997) 2.01
Aging and the anticoagulant response to warfarin therapy. Ann Intern Med (1992) 1.97
Treatment for glaucoma: adherence by the elderly. Am J Public Health (1993) 1.90
The ambiguous relation between aging and adverse drug reactions. Ann Intern Med (1991) 1.82
Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc (1999) 1.82
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry (2001) 1.80
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77
How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med (1997) 1.75
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J (1999) 1.70
Zolpidem use and hip fractures in older people. J Am Geriatr Soc (2001) 1.68
Economic and policy analysis of university-based drug "detailing". Med Care (1986) 1.67
Improving drug use in elderly patients: getting to the next level. JAMA (2001) 1.63
Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol (1989) 1.61
Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment. JAMA (1990) 1.61
Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (1995) 1.60
Psychoactive medication use in intermediate-care facility residents. JAMA (1988) 1.50
Predictors of uncontrolled hypertension in ambulatory patients. Hypertension (2001) 1.49
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia (2005) 1.46
Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis (2001) 1.45
Blood donation by the elderly. Clinical and policy considerations. JAMA (1987) 1.45
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. J Gen Intern Med (1995) 1.41
Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc (1990) 1.41
Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med (1994) 1.41
Late referral and modality choice in end-stage renal disease. Kidney Int (2001) 1.40
Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis (2007) 1.39
Behavior changes after notification of HIV infection. Am J Public Health (1991) 1.38
Quality assurance for drug prescribing. Qual Assur Health Care (1990) 1.38
Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med (2001) 1.33
Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol (1999) 1.32
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene. Am J Public Health (1987) 1.29
The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia (2004) 1.26
Increased antidepressant use in patients prescribed beta-blockers. JAMA (1986) 1.26
Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies. JAMA (1990) 1.25
Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA (1994) 1.24
Systemic effects of medications used to treat glaucoma. Ann Intern Med (1990) 1.24
Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Milbank Mem Fund Q Health Soc (1984) 1.23
A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int (2006) 1.22
Physicians' knowledge of drug costs for the elderly. J Am Geriatr Soc (1994) 1.21
A new approach to reducing suboptimal drug use. JAMA (1983) 1.21
Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol (1997) 1.20
Patterns of drug use in rheumatoid arthritis. J Rheumatol (2000) 1.16
Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol (1999) 1.16
Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant (2007) 1.16
Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. J Clin Epidemiol (2000) 1.15
Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int (2009) 1.14
Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med (2000) 1.13
Predictors of physician prescribing change in an educational experiment to improve medication use. Med Care (1987) 1.11
Nonoccupational risk factors for carpal tunnel syndrome. J Gen Intern Med (1999) 1.11
The neglected medical history and therapeutic choices for abdominal pain. A nationwide study of 799 physicians and nurses. Arch Intern Med (1991) 1.10
Defining "innovativeness" in drug development: a systematic review. Clin Pharmacol Ther (2013) 1.08
Variability in length of hospitalization for stroke. The role of managed care in an elderly population. Arch Neurol (1996) 1.07
Influence of knowledge and attitudes on the quality of physicians' transfusion practice. Med Care (1993) 1.06
Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol (1990) 1.06
Induced disability in nursing home patients: a controlled trial. J Am Geriatr Soc (1982) 1.06
Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA (1990) 1.05
A randomized trial of an education and support program for HIV-infected individuals. AIDS (1995) 1.04
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol (2014) 1.03
The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting. J Am Geriatr Soc (1994) 1.03
Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Med Care (1993) 1.02
Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. Am J Public Health (1988) 1.02
Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int (2012) 1.02
Resident behavior and staff distress in the nursing home. J Am Geriatr Soc (1991) 1.01
Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care (1998) 1.00
Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol (2003) 0.98
Putting adverse drug events into perspective. JAMA (1997) 0.97
Health education about AIDS among seropositive blood donors. Health Educ Q (1986) 0.96
Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med (1996) 0.95
Including elderly people in clinical trials. BMJ (1997) 0.95
A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial. Osteoporos Int (2009) 0.95
Drug prescribing for the elderly. Arch Intern Med (1986) 0.93